Automation & Control

"What's In It for Me?" Taking PAT to the Executive Suite, Part 2

In this audio interview at his offices in Dublin, Paraic O'Toole, CEO of Automsoft, talks about the issues affecting PAT's future. Instead of thinking "technology," he says, corporate executives should view PAT as a tool to improve share prices and profitability. PhRMA could play a far more active role in educating the top brass, and FDA support, at the Commissioner level, would speed PAT's adoption.

By Agnes Shanley, Editor in Chief

Click the Download Now button below to hear Part 2 of this exclusive interview. To hear Part 1 of the interview, click here.

Free Subscriptions

Pharma Manufacturing Digital Edition

Access the entire print issue on-line and be notified each month via e-mail when your new issue is ready for you. Subscribe Today.

pharmamanufacturing.com E-Newsletters

A mix of feature articles and current new stories that are critical to staying up-to-date on the industry, delivered to your inbox. Choose from an assortment of different topics and frequencies. Subscribe Today.